Vertex Pharmaceuticals to acquire Crinetics Pharmaceuticals
Vertex Pharmaceuticals announced plans to acquire Crinetics Pharmaceuticals to bolster its pipeline and revenue projections. The deal is fully funded by committed bridge financing and is expected to contribute to significant growth and accretion by 2029.
View filing at SEC.gov →